Industry: Stadler won a contract worth more than CHF300 million to build 10 trains for Saudi Arabia, with production in Switzerland. Healthcare: Roche reported positive Phase III results for experimental eye drug vamikibart, with vision gains sustained over 52 weeks. Corporate Moves: Sika acquired UK polymeric sands maker Azpects Group, while Swiss medical-technology group Schiller opened a plant in Bosnia. Swiss Economy: Consumers are still spending despite rising prices, and Raiffeisen has raised its growth forecast for the country. Risks: A cyberattack on a software supplier affected Bern pension funds, highlighting the exposure of financial institutions to digital disruption.
AGP Executive Report
Your go-to archive of top headlines, summarized for quick and easy reading.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Pharma: Roche won US approval for Tecentriq with chemotherapy after surgery for a type of stage III colon cancer, adding a new treatment option and a twelfth US indication. Drug Delivery: A Dutch court ordered Merck to stop selling injectable Keytruda in Switzerland and seven other European markets, ruling it infringed a Halozyme patent; Merck disputes the decision. Households: Swiss consumers are still spending despite rising prices, while Raiffeisen has raised its forecast for the country’s economic growth. Business and Technology: A Swiss logistics giant is expanding in China as AI boosts demand, and Swiss SMEs are helping drive an AI-related jobs boom. Pensions: A cyberattack on a software provider exposed Swiss pension funds’ data, sharpening concerns over the sector’s digital security.
Household Spending: Swiss consumers kept spending despite higher prices, with PostFinance’s card-payment indicator up 0.9% year on year in September, though growth has eased since June. Housing Pressure: Swiss cities and tourist hotspots are tightening short-term rental rules as Airbnb listings compete with homes for residents and workers; Lucerne limits some properties to 90 rental nights a year. Logistics and AI: Kuehne+Nagel plans deeper investment in China, citing rising demand for data-centre logistics and the global expansion of Chinese companies. Corporate Deals: Swiss industrial group Sika has acquired British polymeric-sands maker Azpects, while Swiss oil trader Oryx Energies has been sold for $1 billion. Pensions and Tax: Switzerland’s finance minister is defending a proposed VAT rise to help fund higher state pensions, as households face mounting financial pressure.
Public Finance: Switzerland’s finance minister defended a VAT increase to fund higher state pensions, as consumer confidence edged up in September. Markets: Swiss shares fell amid rising oil prices and inflation worries, while concerns grew over possible fuel shortages this autumn. Corporate Moves: Swiss oil trader Oryx Energies was sold for $1 billion; Richemont is cutting jobs at Montblanc, and Sika has bought UK firm Azpects. Trade & Investment: President Guy Parmelin’s India visit produced five agreements spanning trade, mobility and science, with both sides seeking closer investment ties. Finance & Risk: New FINMA customer-onboarding rules and a software-supplier cyberattack affecting Bern pension funds put compliance and operational resilience in focus.
Swiss IPO Watch: Zug-based dental-tech firm vVardis reported first-half revenue more than tripled to $28.6 million in its US IPO filing, though it posted a $27.8 million loss. Corporate Moves: Sika agreed to acquire UK firm Azpects, Nestlé plans to double its Mexico investment to $2 billion, and Richemont is cutting jobs at Montblanc. Finance & Risk: A cyberattack on a software supplier affected Bern pension funds. Swiss consumer confidence edged up in September, while Raiffeisen raised its Swiss growth forecast. Trade Ties: Switzerland and India signed five cooperation agreements and pledged to deepen trade and investment, with a $100 billion investment target under their EFTA trade pact. Markets: Swiss shares fell as rising oil prices revived inflation concerns.
Markets and Growth: Swiss shares fell as rising oil prices revived inflation concerns, while Raiffeisen raised its growth forecast for the Swiss economy. Banking Stability: The Financial Stability Board urged stronger emergency funding plans for failing banks, citing lessons from Credit Suisse’s 2023 rescue. Property: US-based eXp Realty plans to enter Switzerland, its 11th European market, pointing to resilient home prices and lower mortgage rates. Cyber Risk: Switzerland’s federal pension fund reported a data breach after a cyberattack on its software provider. Trade Ties: Switzerland and India signed five agreements spanning trade, mobility, infrastructure and science, alongside a $100 billion investment ambition under their EFTA trade pact. Trade Debate: A Swiss alliance is pushing for a referendum on the Malaysia trade deal, putting the agreement’s domestic support in focus.
Markets: Swiss stocks fell as oil prices and bond yields stoked inflation and interest-rate worries. Growth Outlook: Raiffeisen sharply raised its forecast for Swiss economic growth, offering a brighter view of the domestic economy. Cyber Risk: Switzerland’s federal pension fund reported a data breach after a cyberattack on its software provider. Biotech: Newron shares dropped 5.7% after the US FDA flagged four deaths among patients treated with its experimental schizophrenia drug and raised safety concerns. Trade and Investment: Switzerland and India signed five agreements and pledged to deepen trade and investment ties, including through cooperation on mobility, infrastructure and science. Banking: Zurich-based UBS is exiting fund administration through an expanded deal with Northern Trust, while Swiss liberals lobby against stricter capital requirements for the bank.
Cybersecurity: Swiss federal pension fund Publica is investigating a data leak after an external software provider was hacked; the federal prosecutor has opened an inquiry. Economic Outlook: Raiffeisen raised its 2026 growth forecast for Switzerland to 1.7% from 0.8%, citing a stronger-than-expected economy and pharmaceutical momentum, though energy costs and uncertainty pose risks. UBS Capital Rules: Zurich Liberals are warning that tougher capital requirements could raise costs, curb lending and threaten jobs and tax revenue. Technology and Pharma: Swiss startup ZuriQ and Infineon are expanding work on scalable quantum chips, while Switzerland’s pharma sector is creating new AI-focused career paths. Major Deals: Zurich Insurance has completed its takeover of specialist insurer Beazley; Swiss biotech Alentis also secured a potential $1.6 billion drug-development deal with Australia’s CSL. Trade Ties: President Guy Parmelin’s India visit focused on expanding investment, technology and trade cooperation, with both sides discussing a faster investment treaty.
Capital Markets: Digital Realty closed a CHF510 million Swiss bond offering and priced €1 billion in notes. Property: Swiss home prices continued to rise in the third quarter, though growth has slowed. Consumer Brands: Nestlé’s largest-ever global brand partnership will bring its cocoa and malt drinks brands to NBA audiences in 21 countries, with a goal of getting 2.5 million young people active. India Ties: Talks during President Guy Parmelin’s visit advanced a bilateral investment treaty and wider cooperation in trade, technology and mobility. Innovation: Switzerland topped the 2026 Global Innovation Index for a second year running. Financial Services: Swiss wealth managers are increasingly turning to AI to assess alternative investments. Insurance: Zurich completed its takeover of Beazley, creating a major specialty insurer; Beazley CEO Adrian Cox is stepping down. Jobs: Switzerland’s jobless rate held steady in September.
India–Switzerland Business Push: Swiss President Guy Parmelin’s India visit spotlights trade and investment momentum under TEPA, with talks on fast-tracking a bilateral investment treaty and new pacts spanning mobility, tech, infrastructure and even defence/nuclear cooperation. Swiss Politics & Industry: Switzerland is set to vote on loosening arms-export restrictions on Nov. 29, a referendum that could reshape how Swiss firms supply war materiel and how neutrality is interpreted. Energy Storage Deal: Saft has won 122MWh battery storage contracts in France with Axpo, adding new grid and market-service capacity in Normandy and Centre-Val de Loire for early-2027 delivery. Biotech Funding Reality Check: A report on Europe’s biotech leaders shows deal appetite is rising, but investors still demand stronger data—keeping early-stage financing as the main bottleneck. Travel & Connectivity: Eurostar is adding night-train connections via a new booking tool through Brussels, while SWISS resumes Dubai–Zurich service from Oct. 27 as flight schedules normalize. AI & Compliance Tech: Cardano’s CIP-0113 goes live on mainnet, letting regulated token issuers embed KYC/sanctions and transfer controls directly into token rules. Public Health Support: Roche Diagnostics is supplying molecular testing instruments to boost Ebola testing capacity in the DRC, including training and deployment to Bunia.
India–Switzerland Investment Talks: India’s finance minister met Swiss President Guy Parmelin to push forward negotiations for a Bilateral Investment Treaty, aiming to boost investment flows and deepen economic ties. Swiss Business & Jobs: Zurich completed its Beazley takeover, with Moody’s affirming Zurich’s Aa2 rating after the deal—another signal of consolidation in Swiss insurance. Crypto & Finance: CoinShares says affluent investors in Switzerland and other major markets keep raising crypto exposure, with Bitcoin still the dominant holding. DeFi Risk Watch: New research links flash-loan attacks to $1.211bn losses across 72 incidents (2020–2024), with most losses on Ethereum—useful context for Swiss fintech and risk teams. Textiles Under Pressure: A new ITMF survey shows only slight global improvement for textiles, while Europe remains weak and order backlogs stay short. Healthcare Innovation: Empa is developing visible-light-activated materials for chronic wound patches, targeting a costly Swiss healthcare problem. Swiss Policy & Society: Swiss jobless rate held stable in September, while debate continues around VAT and pension funding pressures.
India–Switzerland diplomacy: PM Narendra Modi and Swiss President Guy Parmelin met in New Delhi, agreeing on deeper cooperation on trade, investment, mobility, tech and supply chains, plus new talks on defence production and nuclear energy. Swiss finance & housing: Switzerland’s VAT hike for the 13th state pension is set for a 29 November vote, while borrowing costs are rising in sync with global bond moves and a study warns Swiss property valuations can diverge by up to CHF 180,000. Wealth management staffing: Julius Baer nominated new board candidates, and Tramondo hired an Asia-focused relationship manager from Cité Gestion. Banking leadership: Banque Richelieu Switzerland appointed Richard Albrecht as CEO, aiming to grow assets from €11bn toward €15bn. AI governance push: A new Swiss public survey backs Switzerland leading global action on AI risks ahead of the Geneva Summit. Business & regulation: Eversheds Sutherland hired a Deloitte forensic investigations veteran; Swiss procurement of a second missile defence system faces delays. Life sciences & fintech: WhiteLab raised $26m to expand AI-designed gene delivery assets; Solana Foundation launched an onchain settlement tool with JPMorgan input. Industry launches: SOMAÍ launched its Soma OG medical cannabis flower in Switzerland via Dascoli Pharma.
India–Switzerland trade push: Prime Minister Narendra Modi and Swiss President Guy Parmelin signed a mobility and migration pact plus four more agreements, aiming to expand Swiss market access for Indian exports and deepen cooperation on defence and nuclear energy under TEPA’s one-year momentum, with a stated target of $100bn investment and major job creation. Swiss business & tech funding: Zurich-based developer infrastructure startup Namespace raised $42m Series B to speed up software engineering and AI-agent workloads, while Swiss AI/compute and token-economy stories also kept investors busy (including Umia’s $6m token auction). Pharma dealmaking: Novartis signed a licensing deal worth up to $7.8bn with China’s Abogen Biosciences for an mRNA autoimmune therapy, underscoring Switzerland’s continued push into high-value biotech partnerships. Energy market moves: MET Group bought a majority stake in Greece’s Zephiros Energy Trading to expand renewable aggregation and battery exposure. Consumer tech pricing: Apple raised Apple One Family and Premier subscription prices in Switzerland and several European countries, adding pressure on household budgets. Entrepreneurship gap: A new GEM report finds women are active in high-potential entrepreneurship but far fewer reach the established stage.
Swiss-India diplomacy: President Guy Parmelin met PM Narendra Modi at Hyderabad House, framing the state visit as a “stepping stone” to deepen ties after the India-EFTA TEPA anniversary, with talks spanning trade, investment, tech, mobility and people-to-people links. Biotech dealmaking: CSL is backing Basel’s Alentis Therapeutics with up to $1.6bn to co-develop and co-commercialise lixudebart for rare kidney and liver diseases, with CSL taking major development costs. Cyber & compliance expansion: SGS completed its majority-stake acquisition of US firm Prescient Security to strengthen its Digital Trust strategy, adding cybersecurity, compliance and certification capabilities. LegalTech funding: Copenhagen’s Pandektes raised €13.5m Series A to build a modern data infrastructure for European legal research, aiming to help firms switch away from entrenched local incumbents. Insurance M&A: Zurich says it has become the “largest” specialty insurer after completing its £8.2bn Beazley takeover, with integration plans and new leadership roles. Markets & FX: The euro slid to a 17-month low on French fiscal worries, while the Swiss franc also strengthened. Swiss business ecosystem: A report highlights a new growth cycle for Swiss CDMOs/CROs as demand rises for complex modalities and preclinical models. Energy & infrastructure: Bangladesh’s LNG expansion plans raise affordability questions as import capacity is set to more than double. Aviation & travel: Middle East flight suspensions and delays continue amid ongoing regional tensions and airspace restrictions. Sports finance angle: Analysis argues live sport’s human element keeps it relatively resilient to AI-driven disruption.
Swiss-India Business Diplomacy: Swiss President Guy Parmelin starts a three-day state visit to India with talks with Narendra Modi, expected to cover trade, investment, science and mobility, and to mark the first anniversary of the India-EFTA trade deal. Swiss Corporate Dealmaking: Zurich Insurance’s $10.8bn Beazley acquisition is now final, with Kristof Terryn set to lead the combined specialty operation (subject to approval). Swiss Watch Industry: A new report highlights how Switzerland’s watch sector is shrinking in volume but “getting swankier”, with a handful of top brands capturing most revenue. Swiss Finance & Crypto: Switzerland’s central bank warns stablecoins could disrupt monetary policy, while UK HMRC announces automatic crypto reporting rules from May 31, 2027—expanding data sharing that includes Switzerland. Global Markets Mood: Inflation worries, sovereign-yield moves and geopolitics kept markets choppy, with the dollar firm and Europe’s fiscal stress in focus. Trade & Commodities: Uganda joins the Swiss Coffee Trade Association, aiming to deepen access to global coffee markets. Biotech Licensing: Novartis signs an up-to-$7.8bn licensing deal with Abogen for mRNA-based therapies, underscoring renewed dealmaking focus.
Swiss Markets & Aviation: Goldman Sachs reiterated a Buy on Flughafen Zurich AG, lifting its price target to CHF260 after the stock closed at CHF195.70. Household Economics: A new guide looks at how Swiss families can cut costs in 2026, starting with health insurance premium reviews and smarter deductible choices. Swiss Finance & Risk: Swiss central bank warnings highlight that stablecoins could disrupt monetary policy, adding to the debate on crypto’s role in Switzerland’s financial system. Global Energy & Geopolitics: US-Russia Ukraine talks reportedly now include a multi-billion-dollar Lukoil oil deal, potentially tied to sanctions and Middle East business interests. Swiss Business & Travel Tech: Entravel Group raised $7.5m to expand its white-label travel booking stack, including a stablecoin-enabled finance layer. Swiss Space: A Swiss space firm, s2a systems, shared footage amid investigations into why the US spy satellite USA 32 fragmented in orbit.
Swiss Ukraine Aid: The Swiss Federal Council approved CHF 135m (about $162m) for eight Ukraine reconstruction projects run by Swiss firms, targeting the energy grid, public transit and municipal water, with training and job support for Ukrainian engineers. Swiss Finance & Regulation: Julius Baer’s Swiss regulator probe has ended with “serious” AML violations findings, clearing the way for a potential share buyback, while earlier coverage also flagged Swiss banking outperformance and a Julius Baer probe. Swiss Business Expansion: Entravel Group raised $7.5m to expand its white-label travel “rails” into fintech-style settlement and working-capital finance, leveraging hotel inventory embedded across 40+ branded platforms, including in Switzerland. Swiss Tech & Cyber: Beyond Gravity’s space firm reported a cyberattack, adding to a busy week for Swiss companies operating in high-risk tech sectors. Global Markets Watch: Argentina launched a citizenship-by-investment plan for foreigners investing $350,000+ (or an $800,000 bond), a reminder of how capital mobility keeps reshaping policy. Drought Impact in Switzerland: “HELP” signs appeared on the dried Lake Brenets lakebed as an extreme low-rainfall spell threatens tourism and local livelihoods. Luxury Retail Signal: Axis Securities reiterated a BUY on India’s Ethos (luxury watches), citing plans to triple boutiques and a push up the global horology map.
Swiss Corporate Leadership: Rieter appoints Daniel Lippuner as CEO from 1 Nov 2026, with Thomas Oetterli stepping down and Carl Illi taking the board chair until April 2027. Private Markets Transparency: A Wealth 30 survey finds European wealth managers often engage in private markets but rarely explain them clearly; Swiss banks rank best on communication. Banking & Regulation: Swiss regulator ends proceedings against Julius Baer after finding serious AML and risk breaches, raising questions about potential buy-back and governance fallout. Markets & FX: Global shares rose as bond and currency volatility eased and oil fell after weaker US jobs data; the dollar strengthened while the euro slid. Swiss Economy & Policy: Switzerland’s bet on carbon offsets shows little payoff so far, while Swiss health premiums keep rising amid ageing pressures. International Trade Links: Azerbaijan and Switzerland discussed expanding cooperation in industry, renewables, digital tech, agriculture and tourism, plus humanitarian demining. Energy & Industry: Pure Cycle Power plans to expand in Bulgaria with Burgas State University, offering internships and thesis projects tied to waste-to-clean-energy hydrogen syngas work. Humanitarian Finance: UNHCR warns 5.8m refugee children were out of school in 2025, with funding cuts threatening further setbacks.
Swiss Politics: President Guy Parmelin says he will step down from the Federal Council at the end of 2026, after 11 years in government, citing a fast-changing world and new pressures including geopolitics and AI. Ukraine Reconstruction: Switzerland will fund eight projects run by Swiss firms to rebuild Ukraine, with 135m francs targeting energy, public transport and water management. Swiss Business & Markets: Swiss Franc strength and bond-market jitters are in focus as markets react to global rates and the latest jobs data. Trade & Economy: India–EFTA’s first year is reviewed, with Switzerland dominating trade and gold imports rising sharply, while other sectors show mixed early results. Healthcare & Pharma: Novartis signs a licensing deal with China’s Abogen for an mRNA autoimmune therapy worth up to $7.8bn, as Big Pharma leans on Chinese biotech. Corporate Moves: WISeSat.Space, backed by WISeQey, completes its business combination and starts trading on Nasdaq under “SAIQ”. Food & Compliance: An FDA warning letter about Listeria at an Ohio cheese co-op was posted months after it was issued, raising questions on timing and transparency. Trade Flows: Moroccan blueberry exports to Switzerland jump 75% in 2026, reinforcing Switzerland’s reliance on imports. Security & IT: Heimdal expands MSP security distribution across DACH via Elovade.
Biotech Leadership Shake-ups: Pharming’s CEO Fabrice Chouraqui exits after strategy misalignment; Evotec loses CSO Cord Dohrmann; Nanobiotix appoints a new CFO, as Swiss biotech management reshuffles continue. Regulatory & Pharma Deals: Novartis signs a roughly $7.8bn mRNA/RNA licensing deal with China’s Abogen, while Addex brings back Jean-Philippe Rocher to lead pharmaceutical development. Energy Grid Costs: Swissgrid cut first-half balancing procurement costs by 50% to CHF150.1m, helped by a new imbalance pricing mechanism and AI optimisation, alongside CHF164.8m in transmission modernisation. Markets & FX Pressure: Global investors brace for US jobs data as bond yields hit multi-decade highs; the euro slides and the Swiss franc benefits. Climate & Water Risks: Europe’s major rivers hit record-low flows, while Swiss glaciers lost nearly 20% of ice since 2021—raising stakes for transport, power and hazards. Travel Rules: The EU’s new border entry/exit system expands to include Switzerland, with biometric checks for many travellers. Corporate Moves: Zurich completes its $10.8bn Beazley takeover; Nestlé appoints Manuela Bernasconi as Group General Counsel from Jan 2027.
Sign up for:
Business Daily Switzerland
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.